GENNQ (Genesis Healthcare) EBITDA: $168 Mil (TTM As of Dec. 2020)


GENNQ Genesis Healthcare Inc GENNQ
12 GF Score
Price $0.00
View Full Analysis

What is Genesis Healthcare EBITDA?

Genesis Healthcare GENNQ -99.00% 12 EBITDA is $168 Mil as of Dec. 2020. GuruFocus rates GENNQ with a GF Score™ of 12/100.

Genesis Healthcare's EBITDA for the three months ended in Dec. 2020 was $38 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 was $168 Mil.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

Genesis Healthcare's EBITDA per Share for the three months ended in Dec. 2020 was $0.33. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2020 was $1.11.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

Genesis Healthcare  (OTCPK:GENNQ) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Genesis Healthcare EBITDA Related Terms


Genesis Healthcare EBITDA Historical Data

* Premium members only.

The historical data trend for Genesis Healthcare's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genesis Healthcare EBITDA Chart

Genesis Healthcare Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 647.49 -214.43 309.79 312.78 136.30

Genesis Healthcare Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.64 131.64 35.95 -37.46 37.68

GENNQ vs AIH, JYNT, AVCO: EBITDA Comparison

For the Medical Care Facilities subindustry, Genesis Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genesis Healthcare EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Genesis Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Genesis Healthcare's EV-to-EBITDA falls into.


GENNQ
12GF Score
Genesis Healthcare Inc GENNQ
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Genesis Healthcare's EBITDA for the fiscal year that ended in Dec. 2020 is calculated as

Genesis Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Dec. 2020, Genesis Healthcare's EBITDA was $136 Mil.

Genesis Healthcare's EBITDA for the quarter that ended in Dec. 2020 is calculated as

Genesis Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2020, Genesis Healthcare's EBITDA was $38 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $168 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of $168 Mil mean?
Genesis Healthcare (GENNQ) has a EBITDA of $168 Mil as of Dec. 2020. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Genesis Healthcare.
Is Genesis Healthcare's EBITDA too high?
Genesis Healthcare's current EBITDA is $168 Mil. Overall, Genesis Healthcare has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Genesis Healthcare's EBITDA compare to AIH and JYNT?
Genesis Healthcare's EBITDA of $168 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Healthcare Providers & Services company?
A good EBITDA depends on the Healthcare Providers & Services industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Genesis Healthcare. Genesis Healthcare's current EBITDA is $168 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genesis Healthcare stock overvalued right now?
Genesis Healthcare (GENNQ) has a current EBITDA of $168 Mil. The current EBITDA is $168 Mil. Genesis Healthcare's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Genesis Healthcare (GENNQ), the current EBITDA is $168 Mil as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genesis Healthcare Business Description

Address 101 East State Street, Kennett Square, PA, USA, 19348
Genesis Healthcare Inc is a post-acute care provider in the United States. It focuses on the medical and physical issues facing elderly patients and is provided by the employees of skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business. The company has three operating segments. The inpatient services segment include the operation of skilled nursing facilities and assisted/senior living facilities; rehabilitation therapy segment services include integrated and third-party rehabilitation and respiratory therapy services; and all other services. The majority of its revenue is generated from its skilled nursing facilities of the inpatient services segment.
12GF Score

Get the complete analysis for GENNQ

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price